Table 5.
The non-motor symptoms of patients with PD at baseline and after 12 weeks of intervention.
| Outcomes | Baseline (V0) | Post-12 weeks (V1) | p | ||
|---|---|---|---|---|---|
| Total NMSS | 6.84 ± 4.65 (5) | Range 0–18 | 6.28 ± 4.35 (6) | Range 0–16 | 0.115 |
| NMS Domain, % | No | Yes | No | Yes | p' |
| Gastrointestinal tract | 24 | 76 | 20 | 80 | 0.625 |
| Urinary tract | 60 | 40 | 48 | 52 | 0.063 |
| Sexual function | 48 | 52 | 48 | 52 | 1 |
| Cardiovascular | 80 | 20 | 80 | 20 | 1 |
| Cognitive function | 44 | 56 | 44 | 56 | 1 |
| Mood disorders | 68 | 32 | 80 | 20 | 1 |
| Sleep disorders | 68 | 32 | 68 | 32 | 0.727 |
| Impulse control disorders | 100 | 0 | 100 | 0 | NA |
| Others | 48 | 52 | 48 | 52 | 1 |
| BDI-II | 8.6 ± 6.4 (7) | 1–25 | 7.64 ± 7.08 (5) | 0–34 | 1.000 |
| PAC-SYM | 7.8 ± 4.92 (8) | 0–17 | 6.32 ± 5.1 (5) | 0–20 | 0.108 |
Mean ± SD (Medium); p', Chi square; NMSS, Non-Motor Symptoms Scale; BDI-II, Beck Depression Inventory-II; PAC-SYM, patient assessment of constipation symptoms.